Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017)

Filip Raciborski; Karina Jahnz-Rozyk; Anna Kłak; Adam J. Sybilski; Aleksandra M. Grąbczewska; Melania Brzozowska; Andrzej M. Śliwczyński

doi:10.5114/ada.2018.79099

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2019
vol. 36

Send email

Copy url:

abstract:

Original paper

Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017)

Filip Raciborski

¹

,

Karina Jahnz-Rozyk

²

,

Anna Kłak

¹

,

Adam J. Sybilski

¹

,

Aleksandra M. Grąbczewska

¹

,

Melania Brzozowska

³

,

Andrzej M. Śliwczyński

^{4, 5}

Department of the Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland
Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine, Warsaw, Poland
Department of Drug Administration, National Health Fund, Warsaw, Poland
Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland
Department of Analyses and Strategies, National Health Fund, Warsaw, Poland

Adv Dermatol Allergol 2019; XXXVI (6): 727-733

DOI: https://doi.org/10.5114/ada.2018.79099

Online publish date: 2018/10/19

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Raciborski F, Jahnz-Rozyk K, Kłak A, et al. Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017). Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2019;36(6):727-733. doi:10.5114/ada.2018.79099.

APA

Raciborski, F., Jahnz-Rozyk, K., Kłak, A., Sybilski, A., Grąbczewska, A.,  & Brzozowska, M. et al. (2019). Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017). Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 36(6), 727-733. https://doi.org/10.5114/ada.2018.79099

Chicago

Raciborski, Filip, Karina Jahnz-Rozyk, Anna Kłak, Adam J. Sybilski, Aleksandra M. Grąbczewska, Melania Brzozowska,  and Andrzej M. Śliwczyński. 2019. "Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017)". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 36 (6): 727-733. doi:10.5114/ada.2018.79099.

Harvard

Raciborski, F., Jahnz-Rozyk, K., Kłak, A., Sybilski, A., Grąbczewska, A., Brzozowska, M.,  and Śliwczyński, A. (2019). Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017). Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 36(6), pp.727-733. https://doi.org/10.5114/ada.2018.79099

MLA

Raciborski, Filip et al. "Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017)." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 36, no. 6, 2019, pp. 727-733. doi:10.5114/ada.2018.79099.

Vancouver

Raciborski F, Jahnz-Rozyk K, Kłak A, Sybilski A, Grąbczewska A, Brzozowska M et al. Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017). Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2019;36(6):727-733. doi:10.5114/ada.2018.79099.

Introduction
Epidemiological data indicate significant differences in atopic dermatitis (AD) prevalence between countries.

Aim
The purpose of this study is to (i) analyse the recorded prevalence of atopic dermatitis (diagnoses of AD reported to the Polish National Health Fund (NHF)) and to (ii) estimate direct costs of medical care for AD incurred by the NHF.

Material and methods
The analysis was based on data reported to the database of the public payer (NHF). The prevalence rates were calculated using the NHF data and population estimates were obtained from the Central Statistical Office of Poland (GUS).

Results
In 2017, the annual prevalence rate of AD in the Polish population was 32.5 per 10,000 inhabitants (34.7/10,000 for women and 30.1/10,000 for men). The highest prevalence was observed in the youngest age groups (300/10,000 in children up to 4 years of age and 141/10,000 in 5–9-year-olds). The prevalence rate decreased with age and AD was the least prevalent in patients over 85 years of age (4/10,000). In 2008–2017, NHF expenditure on AD treatment varied between PLN 19.9 million (EUR 5.6 million) in 2008 and PLN 28.4 million (EUR 6.5 million) in 2016.

Conclusions
The prevalence rates of AD in Poland estimated on the basis of NHF data are significantly lower than those reported in previous epidemiological studies conducted in Poland and worldwide. This may indicate that the prevalence of AD in the Polish population is underestimated or that there are no adequate disease control measures in patients with a confirmed diagnosis.

keywords:

Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008–2017)

Filip Raciborski 1 , Karina Jahnz-Rozyk 2 , Anna Kłak 1 , Adam J. Sybilski 1 , Aleksandra M. Grąbczewska 1 , Melania Brzozowska 3 , Andrzej M. Śliwczyński 4, 5

atopic dermatitis, atopic eczema, epidemiology, direct costs

Filip Raciborski

¹

,

Karina Jahnz-Rozyk

²

,

Anna Kłak

¹

,

Adam J. Sybilski

¹

,

Aleksandra M. Grąbczewska

¹

,

Melania Brzozowska

³

,

Andrzej M. Śliwczyński

^{4, 5}